[Lecture Report] The Pharmaceutical Manufacturers Association of Japan Media Forum – “Preparing for Antimicrobial Resistance (AMR) Awareness Month” (November 8, 2022)
date : 11/28/2022
Tags: AMR
Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno gave a lecture titled, “Efforts of AMR Alliance Japan” at the Pharmaceutical Manufacturers Association of Japan’s Media Forum titled, “Preparing for Antimicrobial Resistance (AMR) Awareness Month.” The forum was organized by the International Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) in cooperation with AMR Alliance Japan. The lecture focused on the efforts of AMR Alliance Japan undertaken for seven main themes and discussed the importance of awareness-raising activities and public collaboration.
Speakers (Titles omitted, in order of presentation)
Akiko Honda (Parliamentary Vice-Minister, Health, Labour and Welfare)
Tomohiro Onishi (Deputy Director-General, Office for COVID-19 and Other Emerging Infectious Disease Control, Cabinet Secretariat)
Kazuhiro Tateda (Committee Chairman, Joint Review Committee of the Seven Academic Societies for the Promotion of Infectious Disease Therapy and Drug Discovery; Professor, Department of Microbiology and Infectious Diseases, Toho University)
Yui Kohno (Manager, Health and Global Policy Institute)
Yusuke Ariyoshi (Leader, Infectious Disease Group Chair, Global Health Subcommittee International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
AMR Alliance Japan is an independent platform for multi-stakeholder discussions on AMR measures that was established in November 2018. Since its establishment, AMR Alliance Japan has worked with Alliance members and partner organizations to deepen the policy debate around AMR. One result of these activities was the presentation of “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures” in July 2019. Moving forward, the Alliance will take every opportunity to explain these recommendations to AMR policy stakeholders and take steps toward concrete policy action on AMR.
AMR Alliance Japan was established in November 2018 as a multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. As of November 2022, its members include MSD K.K., The Children and Healthcare Project, Shionogi & Co., Ltd., Sumitomo Pharma Co., Ltd., The Japanese Society of Antimicrobials for Animals, NISSUI Pharmaceutical Co., Ltd., Nippon Becton Dickinson Co., Ltd., The Japan Medical Association, The Japanese Society for Medical Mycology, The Japanese Society of Pharmaceutical Health Care and Sciences, The Japanese Society of Chemotherapy, The Japanese Society for Infection Prevention and Control, The Japanese Association for Infectious Diseases, The Japanese Society for Pediatric Infectious Diseases, The Japan Pharmaceutical Manufacturers Association, The Japanese Society of Therapeutic Drug Monitoring, The Japan Society of Hospital Pharmacists, The Pharmaceutical Society of Japan, The Japan Pharmaceutical Association, The Japanese Society for Clinical Microbiology, bioMérieux Japan Ltd., Himeji City, Pfizer Japan Inc., and Meiji Seika Pharma Co., Ltd. Health and Global Policy Institute (HGPI) serves as its secretariat.
【Seven Policy Recommendations by AMR Alliance Japan】
1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities.
2. Constructing domestic AMR surveillance and crisis management systems.
3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology.
4. Supporting education on AMR for the public and medical practitioners.
5. Establishing incentive models to encourage R&D for antimicrobials.
6. Stabilizing the supply of antimicrobials.
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)